Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens

The standard of care for patients with acute promyelocytic leukaemia (APL) relapsing after front‐line treatment with arsenic trioxide (ATO)‐based regimens remains to be defined. A total of 67 patients who relapsed after receiving ATO‐based up‐front therapy and were also salvaged using an ATO‐based r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Haematol
Hlavní autoři: Fouzia, N. A., Sharma, Vibhor, Ganesan, Saravanan, Palani, Hamenth K., Balasundaram, Nithya, David, Sachin, Kulkarni, Uday P., Korula, Anu, Devasia, Anup J., Nair, Sukesh C., Janet, Nancy Beryl, Abraham, Aby, Mani, Thenmozhi, Lakshmanan, Jeyaseelan, Balasubramanian, Poonkuzhali, George, Biju, Mathews, Vikram
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Haematological Malignancy ‐ Clinical
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894296/
https://ncbi.nlm.nih.gov/pubmed/33216980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17221
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky